Wolverine Trading, LLC United Therapeutics Corp Transaction History

Wolverine Trading, LLC

  • $96.9 Billion
  • Q2 2025

A detailed history of Wolverine Trading, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 1,307 shares of UTHR stock, worth $565,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,307
Holding current value
$565,525
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 18, 2025
BUY
$276.47 - $328.4 $361,346 - $429,218
1,307 New
1,307 $375,000
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $218,344 - $262,238
1,074 New
1,074 $223,000
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $361,338 - $431,693
-2,009 Reduced 45.46%
2,410 $447,000
Q2 2021

Aug 06, 2021
BUY
$170.47 - $211.93 $319,972 - $397,792
1,877 Added 73.84%
4,419 $782,000
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $55,110 - $62,596
-358 Reduced 12.34%
2,542 $421,000
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $295,423 - $440,191
2,900 New
2,900 $431,000
Q4 2019

Feb 12, 2020
SELL
$78.31 - $95.34 $193,660 - $235,775
-2,473 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $609,653 - $700,388
-8,145 Reduced 76.71%
2,473 $200,000
Q1 2018

May 15, 2018
SELL
$107.21 - $151.94 $781,132 - $1.11 Million
-7,286 Reduced 40.69%
10,618 $1.19 Million
Q4 2017

Feb 14, 2018
BUY
$118.58 - $151.28 $1.92 Million - $2.44 Million
16,152 Added 921.92%
17,904 $2.65 Million
Q3 2017

Nov 15, 2017
BUY
$114.6 - $136.81 $200,779 - $239,691
1,752
1,752 $205,000

Others Institutions Holding UTHR

# of Institutions
747
Shares Held
43.9M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $19.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email